Charta Health: A growth foundation, with agents doing the heavy lifting.

Charta Health sells AI chart review into provider organizations. Every encounter gets reviewed before the bill goes out, catching the coding and documentation gaps that would otherwise turn into denials or unbilled revenue. Bain Capital Ventures led their Series A in 2025.

The evaluation pulls in revenue cycle leaders, compliance, clinical leadership and finance, and each of them cares about a different proof point. It is a category where accuracy is the product, so the marketing has to carry evidence, not adjectives.

The constraint was throughput, not strategy. A small marketing team in a technical, regulated category can publish slowly and correctly, or quickly and badly. Meanwhile the searches that matter, the coding and compliance questions their buyers type at eleven at night, were being answered by trade publishers and competitors instead of by the company that automates the work.

We audited what was already there before adding anything. The go-to-market stack got reviewed for whether it could carry more volume: how leads enter, where they land, what fires when, and which parts were doing the same job twice.

In parallel we tightened the story. ICP definitions by practice type and by role. Positioning that leads with the operational and financial outcome, not the model architecture. And a 90 day roadmap, so the sequence was explicit and the team knew what was deliberately not being done yet, which in my experience is the half that saves the quarter.

Pointing a language model at a keyword list produces volume and nothing else. The model has no access to the things that make content rank and convert: the real objections, the specific numbers, the category vocabulary, the house style.

So we built a pipeline instead of a prompt. The demand map comes first, high intent clusters plus the programmatic families where one well-structured template serves a large group of closely related searches. Then agents do the research and briefing: assembling evidence, tearing down the pages currently ranking, listing the entities that have to appear, proposing the internal links. What comes out is a draft already shaped correctly. The human time goes where it is worth the money, which in a clinical category is accuracy review and point of view.

The step that makes it stick is wiring the agents into the content production lifecycle, not running them ad hoc. Publishing becomes a cadence with a queue behind it, not a burst of effort that decays the moment the quarter gets busy.

Healthcare conferences still generate a real share of pipeline, and most of it evaporates in the two weeks after the badge scan.

Event leads now enter sequences built around what that person actually saw and said, not a generic post-show blast. Lifecycle sequences cover onboarding, retention and waking up dormant contacts. All of it reports back through closed-loop tracking, so the return on an event or a lifecycle program is a number someone can defend in a budget conversation.

A documented view of their own go-to-market infrastructure. Positioning and ICP definitions the whole team can repeat. A 90 day roadmap with the sequence made explicit. An agent-assisted content engine that turns a keyword cluster into a reviewed, on-brand page without adding headcount. Event and lifecycle nurture that runs itself. And the attribution to say which of it worked.

A foundation engagement is only worth the money if it keeps producing after I leave, so that is what we design for and what we measure against.